ZEPBOUND

Description

This research-grade dual agonist compound enables scientific investigation into the simultaneous activation of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It represents a valuable tool for studying the “twincretin” mechanism in laboratory settings, allowing researchers to examine how combined receptor activation produces distinct metabolic effects compared to single-pathway stimulation.

Primary Laboratory Applications:

• Synergistic receptor activation and downstream signaling research

• Comparative metabolic studies: GIP-only vs GLP-1-only vs dual activation

• Adipose tissue browning and thermogenesis mechanism studies

• Insulin sensitivity modulation through dual pathway investigation

• Receptor binding affinity ratio and specificity research

Research Specifications:

• Molecular Weight: 4813.49 Da

• Amino Acid Sequence: H-Tyr-Aib-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Gln-Asp-Phe-Ile-Asn-Trp-Leu-Leu-Lys(AEEA-AEEA-yGlu-17-carboxyheptadecanoyl)-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

• Stability: Stable for 30 days after reconstitution when refrigerated

• Research Notes: Particularly valuable for comparative mechanism studies